Related Experiment Video
Updated: Jun 14, 2026
13:35
A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
Published on: March 1, 2018
Urinary catecholamine levels and response to group cognitive behaviour therapy in depression
Tian P S Oei1, Genevieve A Dingle, Molly McCarthy
1School of Psychology, University of Queensland, Brisbane, Australia. oei@psy.uq.edu.au
Behavioural and Cognitive Psychotherapy
|March 27, 2010
Summary
Individuals with high catecholamine (CA) levels, a biological marker for depression, respond as well to group cognitive behaviour therapy (CBT) as others. This indicates CBT is effective regardless of CA excretion levels.
Area of Science:
- Psychiatry
- Neuroscience
- Behavioural Science
Background:
- Depression is a complex mood disorder with potential biological underpinnings.
- Catecholamines (CA) are neurotransmitters implicated in stress response and mood regulation.
- Previous research has explored the link between CA levels and depression severity.
Purpose of the Study:
- To determine if high urinary catecholamine (CA) excreters show a diminished response to group cognitive behaviour therapy (CBT) for depression.
- To compare treatment outcomes for depression based on pre-therapy CA excretion levels.
Main Methods:
- 70 adults with depression symptoms underwent a 12-week group CBT program.
- Participants were categorized into High, Low, or Mixed CA excreters based on 24-hour urinary CA levels.
- Depression and cognitive measures, including the Beck Depression Inventory (BDI), were assessed pre- and post-therapy.
Main Results:
- All three CA groups demonstrated equivalent mood improvement rates throughout the CBT treatment.
- High CA excreters, on average, remained more depressed during the study but still improved.
- Cognitive measure improvements paralleled symptom changes across all catecholamine groups.
Conclusions:
- Elevated catecholamine levels, a biological marker, do not impede the ability of adults with depression to benefit from group CBT.
- Group CBT is an effective treatment for depression, irrespective of an individual's catecholamine excretion profile.
- Findings support the broad applicability of CBT for depression, including in individuals with potential biological markers.
Related Concept Videos
01:25Cognitive Therapy
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:24Rational Emotive Behavior Therapy
Cognitive-behavioral therapies (CBTs) are grounded in the belief that our thoughts profoundly influence our emotions and actions. Advocates of CBT emphasize three core assumptions: first, that cognitions are identifiable and measurable; second, that they are central to psychological functioning; and third, that irrational or maladaptive beliefs can be replaced with rational and adaptive ones. This transformative approach to therapy has paved the way for specific models such as Albert Ellis's...